Concepedia
3
Publications
92
Citations
H-Index
2017
Active since
Affiliations
Selecta Biosciences (United States)(Current)
Massachusetts General Hospital
Altoona Center for Clinical Research
Rehan Azeem is an author at Selecta Biosciences (United States).
Publications per year
2017–2023
Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial
Julio Rosenstock, John B. Buse, Rehan Azeem et al. · Diabetes Care · 2017 · 53 citations · Full text
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
Alan Kivitz, Wesley DeHaan, Rehan Azeem et al. · Rheumatology and Therapy · 2023 · 21 citations · Full text
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout
Herbert S. B. Baraf, Puja Khanna, Alan Kivitz et al. · Lara D. Veeken · 2023 · 18 citations · Full text
Rows per page
1–3 of 3